Paper Details

  1. Home
  2. Paper Details

Bupropion SR for the treatment of smokeless tobacco use.

Author: CroghanIvana T, DaleLowell C, EbbertJon O, GloverElbert D, HurtRichard D, SchroederDarrell R, SeversonHerbert H

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

Bupropion SR, a medication for smoking cessation, is being evaluated for its efficacy and safety in reducing smokeless tobacco (ST) use. No pharmacotherapies have been shown to effectively increase long-term abstinence rates for ST users, but bupropion SR shows potential in pilot studies.
Paper Details　
Original Abstract of the Article :
No pharmacotherapies have been shown to increase long-term (> or = 6 months) tobacco abstinence rates among smokeless tobacco (ST) users. Bupropion SR has demonstrated potential efficacy for ST users in pilot studies. We conducted a multicenter, randomized, double-blind, placebo-controlled, clinical...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/17353101

データ提供：米国国立医学図書館（NLM）

Bupropion SR for the Treatment of Smokeless Tobacco Use

In the world of [addiction], finding effective treatments for [smokeless tobacco use] is a significant challenge. This study investigated the efficacy and safety of [bupropion SR] for treating [smokeless tobacco use].

Bupropion SR Shows Promise for Smokeless Tobacco Users

This study suggests that [bupropion SR] may be effective in helping people quit [smokeless tobacco]. The authors found that [bupropion SR] was more effective than [placebo] in increasing [tobacco abstinence rates] among [smokeless tobacco users].

Seeking Help for Smokeless Tobacco Use

If you or someone you know struggles with [smokeless tobacco use], there are resources available to help. This study highlights the potential of [pharmacotherapy] to help people quit [smokeless tobacco].

Dr.Camel's Conclusion

This research is a glimmer of hope in the desert of [addiction]. It’s important to note that the journey to quitting [smokeless tobacco] can be challenging. However, this study shows that there are treatment options available that can increase the likelihood of success.
Date :
  1. Date Completed 2007-10-15
  2. Date Revised 2023-11-03
Further Info :

Pubmed ID

17353101

DOI: Digital Object Identifier

NIHMS26951

Related Literature

Article Analysis
・Effective treatment of smokeless tobacco
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.